Robert Cywes, P. Robert C. Harvey, Marian A. Packham, Ross Cameron, Steven M. Strasberg – 1 January 1996 – We have previously shown that part of the injury sustained by cold‐preserved livers on reperfusion is the consequence of platelet adhesion to sinusoidal endothelium. The purpose of the present study was to determine whether prostaglandin E1 (PGE1) can reduce the injury and if so, how to maximize this beneficial effect.

R Romero, J E Lavine – 1 January 1996 – Hepatitis B virus (HBV) DNA contains consensus elements for transactivating proteins whose binding activity in other systems is regulated by inflammatory cytokines. Because HBV replicates within an environment of provoked inflammation, we speculated that the HBV core/pregenomic promoter may be regulated by cytokines produced in response to infection. To evaluate this hypothesis, the HBV core/pregenomic (C/P) promoter and associated cis‐acting elements were placed upstream of a luciferase‐encoding plasmid.

H C Bisgaard, P Nagy, E Santoni‐Rugiu, S S Thorgeirsson – 1 January 1996 – In this study, we used [3H]thymidine labeling of newly synthesized DNA to examine the earliest effects of 2‐acetylaminofluorene (2‐AAF) on the mitotic activation of cells in the adult rat liver, and in situ hybridization analysis to study the expression of three transcription factors (HNF1 beta, HNF3 γ, and HNF4), and two of the genes (α‐fetoprotein [AFP] and albumin) regulated by these factors.

H Shinohara, A Tanaka, T Kitai, N Yanabu, T Inomoto, S Satoh, E Hatano, Y Yamaoka, K Hirao – 1 January 1996 – We continuously measured hepatic absorbance of indocyanine green (ICG) using near‐infrared (NIR) spectroscopy after intravenous bolus injection in rabbits. Hepatic ICG concentration was obtained by subtracting out the absorbance of hemoglobin and other pigments within the liver.

Nancy L. Ascher, Cyrille Féray, Didier Samuel, Michèle Gigou, Valérie Paradis, Marie Françoise David, Catherine Lemonnier – 1 January 1996 – The aim of this open trial was to assess the efficacy and the safety of interferon (IFN) alfa therapy in liver transplant recipients with chronic active hepatitis caused by hepatitis C virus. In July 1991, among 447 liver recipients regularly observed at our institution, 46 had developed HCV‐related chronic active hepatitis defined by piece meal necrosis.

1 January 1996

Nancy Rolando, Jeremy J. Wade, Arie Stangou, Alexander E. S. Gimson, Julia Wendon, John Philpott‐Howard, Mark W. Casewell, Roger Williams – 1 January 1996 – The efficacy of prophylactic parenteral antibacterials, with or without selective decontamination of the digestive tract, was compared in patients with acute liver failure (ALF) or severe acetaminophen hepatotoxicity.

Victor L. Scott – 1 January 1996

1 January 1996

Giorgio La Villa, Donato Riccardi, Chiara Lazzeri, Vincenzo Casini Raggi, Antonio Dello Sbarba, Cristina Tosti Guerra, Caterina Fronzaroli, Marco Foschi, Giacomo Laffi, Paolo Gentilini – 1 December 1995 – Patients with cirrhosis and ascites have high plasma levels of atrial (ANP) and brain (BNP) natriuretic peptides, two cardiac hormones released by the atria and ventricles, respectively.